amir ahmed toor
Department of Internal Medicine, Massey Cancer Center, Virginia Commonwealth University
United States
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Genetic Variants as Targets for Immunotherapy of Hematological Tumors
Genetic Variants as Targets for Immunotherapy of Hematological Tumors
22k
Total downloads
82k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
88 Authors
anastasia xagara
Department of Immunopathology, Sanquin Research
Netherlands
andreas mackensen
Department of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen-Nuremberg
Germany
anita n. kremer
Department of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen-Nuremberg
Germany
annika nelde
Department of Immunology, Institute for Cell Biology, University of Tübingen
Germany
astrid g. s. van halteren
Immunology Laboratory Willem-Alexander Children's Hospital, Leiden University Medical Center
Netherlands
caroline rulleau
Centre de Recherche de l'Hôpital Maisonneuve-Rosemont
Canada
cédric carli
Centre de Recherche de l'Hôpital Maisonneuve-Rosemont
Canada
claude perreault
Department of Immunobiology, Institute for Research in Immunology and Cancer
Canada
cor van den bos
Princess Máxima Center for Pediatric Oncology
Netherlands
cornelis a. m. van bergen
Department of Hematology, Leiden University Medical Center
Netherlands
cynthia hawkins
Hospital for Sick Children, University of Toronto
Canada
...
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 82kTopic views
- 58kArticle views
- 22kArticle downloads